Harold Davidson & Associates’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$821K Sell
9,049
-435
-5% -$39.7K 0.36% 40
2026
Q1
$974K Sell
9,484
-481
-5% -$54.3K 0.47% 37
2025
Q4
$1.25M Sell
9,965
-980
-9% -$125K 0.55% 38
2025
Q3
$1.47M Buy
10,945
+2,347
+27% +$308K 0.67% 35
2025
Q2
$1.17M Sell
8,598
-2,278
-21% -$300K 0.76% 33
2025
Q1
$1.44M Sell
10,876
-370
-3% -$47.1K 0.79% 33
2024
Q4
$1.27M Buy
+11,246
New +$1.3M 0.61% 40

Other funds holding ABT

Harold Davidson & Associates's ABT Position: Q2 2026 in Review

Harold Davidson & Associates reduced its Abbott (ABT) stake by 4.6% in Q2 2026, selling an estimated $39.7K and leaving 9,049 shares worth $821K. The position accounts for 0.36% of the portfolio, ranked #40.

Harold Davidson & Associates first reported a position in ABT in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.47M in Q3 2025. 1,385 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Harold Davidson & Associates held 9,049 shares of Abbott worth $821K as of Q2 2026.
  • Harold Davidson & Associates sold 435 Abbott shares in Q2 2026, an estimated $39.7K.
  • Abbott made up 0.36% of Harold Davidson & Associates's portfolio in Q2 2026, its #40 holding.
  • Harold Davidson & Associates first reported a position in Abbott in Q4 2024 and has held it in 7 quarters since.
  • Harold Davidson & Associates's Abbott position peaked at $1.47M in Q3 2025.
  • 1,385 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Harold Davidson & Associates's 13F filing for Q2 2026, filed 15 Jul 2026.